Safety and FDA regulations for musculoskeletal allografts - Perspective of an orthopaedic surgeon
Safety and FDA regulations for musculoskeletal allografts - Perspective of an orthopaedic surgeon
复制标题
DOI：
10.1097/01.blo.0000165849.32661.5e
复制
发表时间：
2005-06-01
影响因子：
4.2
通讯作者：
Joyce, MJ
中科院分区：
文献类型：
--
作者：
Joyce, MJ
The Musculoskeletal Transplant Foundation Symposium held in September 2003, in Edinburgh, Scotland provided the opportunity for an orthopaedic surgeon experienced in tissue banking and musculoskeletal allograft transplantation to summarize to orthopaedic colleagues the past and current efforts made by the Food and Drug Administration to ensure the safety of allograft tissues, aspects of tissue banking, concerns of allograft safety and future Food and Drug Administration proposals. The review allows an orthopaedic surgeon an understanding of allograft safety issues and provides information for better informed consent to be obtained by the orthopaedic surgeon from the recipient patient.
